## Understanding the Three Compounds ### Orforglipron: The Small Molecule GLP-1 Agonist Orforglipron (LY3502970) is a non-peptide, small molecule GLP-1 receptor agonist developed by Eli Lilly
In this blog post, we delve into what its like to lose weight with semaglutide and answer some common questions that our patients ask
Lipid Derivatives: Why Standard Wins GHK-Cu is available in various forms, including its standard water-soluble form and lipid derivatives like palmitoyl-GHK (Pal-GHK) , which are modified with fatty acids to enhance skin penetration
1,2 It is estimated that 20-50% 3 of individuals with diabetes are affected by gastroparesis, while 30% of individuals with gastroparesis have comorbid diabetes 4
This is the first study to investigate the unique underlying mechanisms related the effects of GLP-1RA on changes in the gut bacterium
It's the start of a new world in beauty as we know it